January 17 @ 2:00 pm – 3:00 pm
Psychedelic assisted therapy such as MDMA and psilocybin for the treatment of mental health conditions such as PTSD and depression has received increased attention since their breakthrough status was designated by FDA. This presentation will provide an overview on the unique role psychedelics may play in the treatment of mental health conditions such as PTSD and depression. A review of the current literature and important gaps in the literature will be provided. Clinical implications and future research for the use of psychedelics for PTSD and depression will be highlighted.
For CEU’s click here to register!
Click here to join without CEU credit!
